Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis
Leander Muheim, Andri Signorell, Stefan Markun, et al.
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Proton pump inhibitor use: systematic review of global trends and practices
L.G.T. Shanika, Andrew Reynolds, Sharon Pattison, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 9, pp. 1159-1172
Open Access | Times Cited: 93
Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015
Francisco Torres-Bondia, Jordi de Batlle, L. Galván, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease
Fraser J Graham, Jocelyn Friday, Pierpaolo Pellicori, et al.
Heart (2023) Vol. 109, Iss. 17, pp. 1294-1301
Open Access | Times Cited: 14
Risk Stratification of QTc Prolongations in Hospitalized Cardiology and Gastroenterology Patients Using the Tisdale Score—A Retrospective Analysis
Julian Steinbrech, Ute Amann, Michael Irlbeck, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 339-339
Open Access
Practices and knowledge of community pharmacists towards the use of proton pump inhibitors: a cross-sectional study in Jordan
Lobna Gharaibeh, Mariam Ahmad Alameri, Mai I. AL-Hawamdeh, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e085589-e085589
Open Access
Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship
Amit Kumar Dutta, Abhinav Jain, Vaneet Jearth, et al.
Indian Journal of Gastroenterology (2023) Vol. 42, Iss. 5, pp. 601-628
Closed Access | Times Cited: 12
The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence
Nele Moreels, Annelies Boven, Oswaldo Gressani, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 3, pp. 608-616
Open Access | Times Cited: 4
Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: Results from the LAPTOP-PPI cluster randomized trial
Manuela Casula, Ilaria Ardoino, Leandro Pierini, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
DepRescribing inapprOpriate Proton Pump InhibiTors (DROPIT): study protocol of a cluster-randomised controlled trial in Swiss primary care
Angela Lisibach, Renata Vidonscky Lüthold, Clémentine Tombez, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e094495-e094495
Open Access
Prevalence and Factors Associated With Proton Pump Inhibitors (PPIs) Use: A Cross‐Sectional Study of PERSIAN Guilan Cohort Study
Sepide Roudgar, Farahnaz Joukar, Kourosh Mojtahedi, et al.
Health Science Reports (2025) Vol. 8, Iss. 2
Open Access
The Protease Inhibitor Amprenavir Protects against Pepsin-Induced Esophageal Epithelial Barrier Disruption and Cancer-Associated Changes
Simon Blaine‐Sauer, Tina L. Samuels, Ke Yan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6765-6765
Open Access | Times Cited: 10
Despite warnings, co‐medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but XS004, a novel oral dasatinib formulation, provides reduced pH‐dependence, minimizing undesirable drug–drug interactions
Gunnar Larfors, Per Andersson, Gérald Jesson, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 4, pp. 644-654
Open Access | Times Cited: 9
Topical Alginate Protection against Pepsin-Mediated Esophageal Damage: E-Cadherin Proteolysis and Matrix Metalloproteinase Induction
Tina L. Samuels, Simon Blaine‐Sauer, Ke Yan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7932-7932
Open Access | Times Cited: 8
Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial
Jérôme Nguyen‐Soenen, Cédric Rat, Aurélie Gaultier, et al.
BMC Health Services Research (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, et al.
World Journal of Cardiology (2023) Vol. 15, Iss. 8, pp. 375-394
Open Access | Times Cited: 7
Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases
Satoru Mitsuboshi, Hirofumi Hamano, Yurika Kuniki, et al.
Annals of Pharmacotherapy (2023) Vol. 57, Iss. 11, pp. 1255-1263
Closed Access | Times Cited: 6
Inappropriate proton-pump inhibitor prescribing in primary care – an observational study with quality circles
Renata Vidonscky Lüthold, Nicole Christin Henz, Connor Fuhrer, et al.
Schweizerische medizinische Wochenschrift (2023) Vol. 153, Iss. 9, pp. 40119-40119
Open Access | Times Cited: 5
Prescribing Patterns of Proton Pump Inhibitors in Germany: A Retrospective Study Including 472 146 Patients
Kate Plehhova, Monika Haering, Joshua Wray, et al.
Journal of Primary Care & Community Health (2023) Vol. 14
Open Access | Times Cited: 5
Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice—A Cross-Sectional Database Study
Yael Rachamin, Levy Jäger, Rahel Meier, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Evolution of proton pump inhibitor prescribing from 2017 to 2021 at 14 secondary and tertiary hospitals in China：a multicentre cross-sectional study
Min Zeng, Yuan Li, Tao Chen, et al.
BMJ Open (2023) Vol. 13, Iss. 7, pp. e072793-e072793
Open Access | Times Cited: 4
Impact of pharmacist-evaluated clinical decision support system alerts on potentially missing or inappropriately prescribed proton pump inhibitors at hospital discharge: a retrospective cross-sectional study
Lee Flückiger, Claudia Zaugg, Rico Fiumefreddo
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 5, pp. 1143-1151
Open Access | Times Cited: 1
Proton pump inhibitors and cardiovascular risk: a critical review
Gustavo Duarte, José Luis García López, Franklin Sosa, et al.
Future Cardiology (2024), pp. 1-16
Open Access | Times Cited: 1
Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol
Mubashira K Sarnaik, Srimy Modi, Yasaswi Pisipati, et al.
Cureus (2021)
Open Access | Times Cited: 8
Importance of different electronic medical record components for chronic disease identification in a Swiss primary care database: a cross-sectional study
Rahel Meier, Thomas Grischott, Yael Rachamin, et al.
Schweizerische medizinische Wochenschrift (2023) Vol. 153, Iss. 10, pp. 40107-40107
Open Access | Times Cited: 3
Patients, Prescribers, and Institutional Factors Associated with Inappropriate Use of Acid Suppressive Therapy in Medical Wards: An Experience of a Single-Center in Saudi Arabia
Ghazwa B. Korayem, Raghad Alkanhal, Raghad Almass, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 5079-5089
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top